ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rennard, S.I.
Right arrow Articles by Vestbo, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Rennard, S.I.
Right arrow Articles by Vestbo, J.
Eur Respir J 2003; 21:557
Copyright ©ERS Journals Ltd 2003


From the Authors

S.I. Rennard1, M. Decramer2, P.M.A. Calverley3, N.B. Pride4, J.B. Soriano5, P.A. Vermeire6 and J. Vestbo7

1 Pulmonary and Critical Care Medicine Section, Dept of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA. 2 Respiratory Division, Catholic University of Leuven, Leuven, Belgium. 3 University of Liverpool, Dept of Medicine, Clinical Sciences Centre, University Hospital Aintree, Liverpool, UK. 4 Thoracic Medicine, National Heart and Lung Institute, Imperial College School of Medicine, London, UK. 5 Worldwide Epidemiology, GlaxoSmithKline Research and Development, Greenford, UK. 6 Dept of Respiratory Medicine, University of Antwerp, Antwerp, Belgium. 7 Dept of Respiratory Medicine, Hvidovre University Hospital, Copenhagen, Denmark

From the authors:

We are pleased to respond to the comments made by C.K. Connolly. We completely agree with the need to dissociate disability from dyspnoea in the clinical assessment of the chronic obstructive pulmonary disease (COPD) patient. Dyspnoea can arise from many inputs, and, while it correlates with airflow limitation, it does so relatively poorly. Dyspnoea can limit performance. We agree with the suggestion that evaluation of exercise performance can assist in the evaluation of COPD patients. Muscle weakness, however, is a better predictor of disability in COPD than airflow, and this weakness may be due not only to detraining, but also to the inflammatory processes and circulating cytokines that characterise some COPD patients. Because of this latter point, we disagree with C.K. Connolly's suggestion that disability in COPD must be related to the measurable forced expiratory volume in one second (or flow/volume loop) abnormalities.

Clearly the chronic obstructive pulmonary disease patient's clinical status reflects not only the impaired airflow, but also other pulmonary and systemic aspects of the disease. We doubt the disease is underdiagnosed; our survey, in fact, focused on diagnosed cases. Among those individuals, we have little doubt that it is underevaluated. C.K. Connolly's suggestion that more aggressive assessment of objective measures in the chronic obstructive pulmonary disease patient is needed is one with which we wholeheartedly agree. More aggressive identification of the undiagnosed individuals will also be important.





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rennard, S.I.
Right arrow Articles by Vestbo, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Rennard, S.I.
Right arrow Articles by Vestbo, J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS